MSDC 0602( MSDC-0602 | MSDC0602 )

Catalog No. M19353 CAS No. 1133819-87-0

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

MSDC 0602
Note

Research use only, not for human use.
Brief Description

MSDC-0602 is an insulin sensitizer potentially for the treatment of diabetes.
Description

MSDC-0602 is an insulin sensitizer potentially for the treatment of diabetes (metabolic modulator).
In Vitro

——
In Vivo

Animal Model:HTF-C diet feeding C57BL6/J mice Dosage:331 ppm MSDC-0602 potassium salt (2-5 μM MSDC-0602 in blood)Administration:oral administration for 12 weeks (after 4 weeks of HTF-C diet) or 3 weeks (16 weeks after HTF-C diet)Result:Induced weight loss, decreased concentrations of plasma ALT and AST and stellate cell activation.Animal Model:HTF-C diet feeding LS-Mpc2-/-C57BL6/J mice Dosage:331 ppm MSDC-0602 potassium salt (2-5 μM MSDC-0602 in blood) Administration:oral administration for 12 weeks (after 4 weeks of HTF-C diet)Result:Induced weight loss, suppressed stellate cell activation.
Synonyms

MSDC-0602 | MSDC0602
Pathway

Others
Target

Other Targets
Recptor

mTOR
Research Area

——
Indication

——

CAS Number

1133819-87-0
Formula Weight

371.4
Molecular Formula

C19H17NO5S
Purity

>98% (HPLC)
Solubility

DMSO : 125 mg/mL 336.56 mM; H2O : < 0.1 mg/mL
SMILES

COc1cccc(c1)C(=O)COc3ccc(CC2SC(=O)NC2=O)cc3
Chemical Name

5-(4-(2-(3-methoxyphenyl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione

1.McCommis KS et al. Hepatology. 2016 Dec 27. doi: 10.1002/hep.29025.

Calculator

molnova catalog